Vincenza Guzzardo
- Cancer Research top 1%
- MicroRNA in disease regulation 11
- Cancer-related molecular mechanisms research 6
- Cell Biology top 1%
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research 5
- Cancer Immunotherapy and Biomarkers 5
- Molecular Biology top 5%
-
- Gastric Cancer Management and Outcomes 8
- Sarcoma Diagnosis and Treatment 5
-
- Esophageal Cancer Research and Treatment 6
- Cholangiocarcinoma and Gallbladder Cancer Studies 6
- Co-authors
- Stefano PiccoloSilvio BicciatoMichelangelo CordenonsiSirio DupontAmbrogio FassinaElena EnzoMatteo FassanMaria Rondina
- Cited by
- Cancer ResearchCell BiologyOncology
- Partner nations
- ItalyUnited KingdomUnited States
In The Last Decade
Vincenza Guzzardo
73 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 114
- Cancer Research 1.2k
- Cell Biology 962
- Oncology 1.1k
- Molecular Biology 2.5k
- Pulmonary and Respiratory Medicine 511
Countries citing papers authored by Vincenza Guzzardo
This map shows the geographic impact of Vincenza Guzzardo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincenza Guzzardo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincenza Guzzardo more than expected).
Fields of papers citing papers by Vincenza Guzzardo
This network shows the impact of papers produced by Vincenza Guzzardo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincenza Guzzardo. The network helps show where Vincenza Guzzardo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Vincenza Guzzardo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 7 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 2 | |
| 5 | 2022 | 6 | |
| 6 | YAP/TAZ activity in stromal cells prevents ageing by controlling cGAS–STINGbreakdown → | 2022 | 184 |
| 7 | 2022 | 13 | |
| 8 | 2021 | 3 | |
| 9 | 2020 | 10 | |
| 10 | 2019 | 28 | |
| 11 | 2019 | 27 | |
| 12 | 2019 | 20 | |
| 13 | 2019 | 6 | |
| 14 | 2019 | 5 | |
| 15 | 2017 | 25 | |
| 16 | 2014 | 5 | |
| 17 | 2013 | 17 | |
| 18 | 2011 | 29 | |
| 19 | A MicroRNA Targeting Dicer for Metastasis Controlbreakdown → | 2010 | 541 |
| 20 | A Mutant-p53/Smad Complex Opposes p63 to Empower TGFβ-Induced Metastasisbreakdown → | 2009 | 650 |
About Vincenza Guzzardo
Vincenza Guzzardo is a scholar working on Cancer Research, Oncology and Gastroenterology, having authored 74 papers that have together received 4.1k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (11 papers), Gastric Cancer Management and Outcomes (8 papers), Esophageal Cancer Research and Treatment (6 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), Cancer-related molecular mechanisms research (6 papers), Pancreatic and Hepatic Oncology Research (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Sarcoma Diagnosis and Treatment (5 papers). The work is most often cited by research in Cancer Research (1.2k citations), Cell Biology (962 citations) and Oncology (1.1k citations). Vincenza Guzzardo has collaborated with scholars based in Italy, United Kingdom and United States. Frequent co-authors include Stefano Piccolo, Silvio Bicciato, Michelangelo Cordenonsi, Sirio Dupont, Ambrogio Fassina, Elena Enzo, Matteo Fassan, Maria Rondina, A. Parenti and Antonio Rosato. Their work appears in journals such as Nature, Cell and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.